Dr. Emily Reiser is the Associate Director of Texas Medical Center Innovation, spearheading the Accelerators for Cancer Therapeutics, Healthtech, and international BioBridge programs. Since joining TMC in 2019, she transitioned from direct engagement with startup founders to overseeing a vast stakeholder network and now leading the recruitment of entrepreneurs in residence. Prior to joining TMC, Emily lead Eventure, an entrepreneurial community organization empowering the next generation of talent in Houston. She also contributed to the successful launch of local medtech startup, Noleus Technologies.
Emily earned her bachelor’s degree in Biology from Emory University and a PhD in Bioengineering from Rice University, where her research focused on drug delivery for cancer immunotherapy.